NCT01412164View on ClinicalTrials.gov

Observational Registry Study: FIREHAWK DES for Treating Coronary Artery Disease (CAD)

NACompletedINTERVENTIONAL
Enrollment

730

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

February 28, 2013

Study Completion Date

January 31, 2017

Conditions
Coronary Artery Disease
Interventions
DEVICE

FIREHAWK biodegradable polymer rapamycin-eluting stent

DES PCI for CAD

Trial Locations (1)

Unknown

Fuwai Hospital, Beijing

All Listed Sponsors
lead

Shanghai MicroPort Medical (Group) Co., Ltd.

INDUSTRY

NCT01412164 - Observational Registry Study: FIREHAWK DES for Treating Coronary Artery Disease (CAD) | Biotech Hunter | Biotech Hunter